COMMUNIQUÉS West-GlobeNewswire

Pledge to #EndTheStigma on Mental Health with assessURhealth™ at HIMSS18
27/02/2018
Tampa, FL, Feb. 27, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC brings its mental and behavioral health screening tool to the exhibit floor for the 2018 HIMSS Conference & Exhibition at the Sands Convention Center [...]
Adventist Health Selects Michelle Fuentes to Lead Adventist Health Sonora
27/02/2018
ROSEVILLE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—today announced the appointment [...]
Health Quality Council of Alberta seeks voice of Albertans to improve healthcare quality
27/02/2018
CALGARY, Alberta, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) is looking for Albertans to join its Patient and Family Advisory Committee to bring the patient and family perspective to [...]
Atrion Corporation Declares Quarterly Cash Dividend
27/02/2018
ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI ) today announced that its Board of Directors declared a quarterly dividend of $1.20 per share on its outstanding shares of Common Stock. [...]
Vital® to Showcase Enhancements to the Vitrea® Enterprise Imaging Solution at HIMSS 2018
27/02/2018
MINNETONKA, Minn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Vital Images, Inc., will feature the latest developments within its powerful Vitrea Enterprise Imaging solution at HIMSS 2018, in booth 843, March 5-9, in Las Vegas, [...]
Micron Solutions, Inc. Announces Multi-Year Exclusive Manufacturing Agreement with its Largest Customer
27/02/2018
FITCHBURG, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (the “Company”) (NYSE American:MICR) is pleased to announce that its wholly owned subsidiary Micron Products, Inc. (“Micron”) with offices in [...]
Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU)
27/02/2018
Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU) Lugano, Switzerland February 27, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality [...]
Dentsply Sirona to Report Fourth Quarter and Fiscal 2017 Results
27/02/2018
YORK, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the Company will report fourth quarter and fiscal 2017 financial [...]
AllSpire Health GPO Adopts Lumere’s Solutions to Support Value-Based Initiatives
27/02/2018
CHICAGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AllSpire Health GPO, LLC—a health system alliance created to escalate the improvement of clinical outcomes, enable greater access to affordable healthcare, ensure economic [...]
Les infirmières et les infirmiers du Canada accueillent favorablement les nouvelles au sujet d’un groupe de travail national sur la mise en place d’un régime d’assurance-médicaments
27/02/2018
OTTAWA, 27 févr. 2018 (GLOBE NEWSWIRE) -- Les infirmières et les infirmiers du Canada accueillent favorablement les récentes nouvelles communiquées dans les médias selon lesquelles l’Honorable Eric Hoskins sera à la [...]
RAMSAY GENERALE DE SANTE : Half-year Results at the end of December 2017
27/02/2018
PRESS RELEASE Paris, 27 February 2018 Half-year results at the end of December 2017 Declining results in a still very negative pricing environment Published half-year turnover down 1.1% to €1,066.4 million, stable on a [...]
RAMSAY GENERALE DE SANTE : Résultats semestriels à fin décembre 2017
27/02/2018
COMMUNIQUE DE PRESSE Paris, le 27 Février 2018 Résultats semestriels à fin décembre 2017 Des résultats en repli dans un contexte tarifaire toujours très pénalisant Chiffre d'affaires semestriel publié en recul de 1,1% à [...]
The EMA Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in HAE Patients Aged 12 Years and Older
27/02/2018
The European Medicines Agency (EMA) Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in Hereditary Angioedema (HAE) Patients Aged 12 Years and Older - EMA's accelerated [...]
SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)
27/02/2018
PHILADELPHIA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing metabolic-based therapies focused on non-alcoholic steatohepatitis (NASH), announced today the [...]
Canada’s nurses welcome reports of a federal pharmacare task force
27/02/2018
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses welcome recent media reports that the Hon. Eric Hoskins will lead a task force on national pharmacare. The Canadian Federation of Nurses Unions (CFNU) has been [...]
Novo Nordisk files for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A
27/02/2018
Bagsværd, Denmark, 27 February 2018 - Novo Nordisk today announced the submission of a Biologics License Applications (BLA) to the US Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to [...]
Vizient, Inc. Awards National Contract to PDC Healthcare for Patient ID Bands
27/02/2018
VALENCIA, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Dynamics Corporation (PDC Healthcare) , a global leader in healthcare identification and patient safety solutions, announced today that it has been awarded a [...]
Scapa Healthcare Unveils Three R&D Centers of Excellence in U.S. and Europe for Development of Innovative, Turn-key, Skin-Friendly Solutions
27/02/2018
WINDSOR, Conn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions, unveiled its three R&D Centers of Excellence . Each Center offers full [...]
Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Using Lipid Nanoparticle (LNP) Delivery Technology
27/02/2018
Intellia researchers achieved 97 percent reduction in serum transthyretin protein levels in mice through a single administration, with a durability of at least 12 months CRISPR/Cas9 administered via LNP was well- [...]

Pages